PeterE.ZageMDPh.D.

Clinical Trials

• Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement Start of enrollment: 2005 Apr 01

  Completed

  Phase 1

• Doxercalciferol in Recurrent Pediatric Solid Tumors Start of enrollment: 2007 Aug 01

  Terminated

  Phase 1

• ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma Start of enrollment: 2007 Sep 01

  Terminated

  Phase 1

• Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma Start of enrollment: 2008 Jan 14

  Completed

  Phase 2

• N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma Start of enrollment: 2009 Dec 01

  Completed

  Phase 1

• Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06

  Recruiting

• N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma Start of enrollment: 2010 Mar 01

  Completed

  Phase 1

• Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma Start of enrollment: 2010 Dec 01

  Completed

  Phase 1

• Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma Start of enrollment: 2011 Dec 01

  Completed

• Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission Start of enrollment: 2012 Jun 01

  Active, not recruiting

  Phase 2

• Molecular-Guided Therapy for Childhood Cancer Start of enrollment: 2014 Jul 08

  Completed

  Not Applicable

• Neuroblastoma Maintenance Therapy Trial Start of enrollment: 2016 Feb 01

  Recruiting

  Phase 2

• Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors Start of enrollment: 2018 Aug 28

  Recruiting

  Phase 1

• Join now to see all